These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 12657102)
1. Histopathological analysis of angiogenic factors in renal cell carcinoma. Yagasaki H; Kawata N; Takimoto Y; Nemoto N Int J Urol; 2003 Apr; 10(4):220-7. PubMed ID: 12657102 [TBL] [Abstract][Full Text] [Related]
2. Angiogenesis in renal cell carcinoma: Evaluation of microvessel density, vascular endothelial growth factor and matrix metalloproteinases. Zhang X; Yamashita M; Uetsuki H; Kakehi Y Int J Urol; 2002 Sep; 9(9):509-14. PubMed ID: 12410931 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma. Raica M; Cimpean AM; Anghel A Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316 [TBL] [Abstract][Full Text] [Related]
4. The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter. Inoue K; Kamada M; Slaton JW; Fukata S; Yoshikawa C; Tamboli P; Dinney CP; Shuin T Clin Cancer Res; 2002 Jun; 8(6):1863-70. PubMed ID: 12060629 [TBL] [Abstract][Full Text] [Related]
5. Thrombospondin-1, vascular endothelial growth factor expression and microvessel density in renal cell carcinoma and their relationship with multifocality. Baltaci S; Orhan D; Göğüş C; Filiz E; Tulunay O; Göğüş O Eur Urol; 2003 Jul; 44(1):76-81; discussion 81. PubMed ID: 12814678 [TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer. Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor - its relation to neovascularization and their significance as prognostic factors in renal cell carcinoma. Song KH; Song J; Jeong GB; Kim JM; Jung SH; Song J Yonsei Med J; 2001 Oct; 42(5):539-46. PubMed ID: 11675683 [TBL] [Abstract][Full Text] [Related]
9. Microvessel density and vascular endothelial growth factor expression in infiltrating lobular mammary carcinoma. Chhieng DC; Tabbara SO; Marley EF; Talley LI; Frost AR Breast J; 2003; 9(3):200-7. PubMed ID: 12752628 [TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor in renal cell carcinoma and the relation to angiogenesis and p53 protein expression. Lee JS; Kim HS; Jung JJ; Park CS; Lee MC J Surg Oncol; 2001 May; 77(1):55-60. PubMed ID: 11344484 [TBL] [Abstract][Full Text] [Related]
11. Correlation of vascular endothelial growth factor and hypoxia-inducible factor-1α expression with pathological renal artery changes in patients with renal cell carcinoma. Demirović A; Tomas D; Tomić K; Spajić B; Ibukić A; Cupić H; Krušlin B Scand J Urol; 2014 Feb; 48(1):34-40. PubMed ID: 24256617 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis. Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229 [TBL] [Abstract][Full Text] [Related]
13. TGF beta1 expression and angiogenesis in colorectal cancer tissue. Xiong B; Gong LL; Zhang F; Hu MB; Yuan HY World J Gastroenterol; 2002 Jun; 8(3):496-8. PubMed ID: 12046078 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma. Zheng S; Han MY; Xiao ZX; Peng JP; Dong Q World J Gastroenterol; 2003 Jun; 9(6):1227-30. PubMed ID: 12800229 [TBL] [Abstract][Full Text] [Related]
15. Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma. Tomisawa M; Tokunaga T; Oshika Y; Tsuchida T; Fukushima Y; Sato H; Kijima H; Yamazaki H; Ueyama Y; Tamaoki N; Nakamura M Eur J Cancer; 1999 Jan; 35(1):133-7. PubMed ID: 10211101 [TBL] [Abstract][Full Text] [Related]
16. Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in an experimental model of kidney transplantation. Lario S; Mendes D; Bescós M; Iñigo P; Campos B; Alvarez R; Alcaraz A; Rivera-Fillat F; Campistol JM Transplantation; 2003 May; 75(10):1647-54. PubMed ID: 12777850 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of urinary vascular endothelial growth factor and microvessel density in patients with renal cell carcinoma. Chang SG; Jeon SH; Lee SJ; Choi JM; Kim YW Urology; 2001 Dec; 58(6):904-8. PubMed ID: 11744455 [TBL] [Abstract][Full Text] [Related]
19. The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N Cancer; 1999 Oct; 86(8):1455-62. PubMed ID: 10526273 [TBL] [Abstract][Full Text] [Related]
20. Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer. Giatromanolaki A; Koukourakis MI; Stathopoulos GP; Kapsoritakis A; Paspatis G; Kakolyris S; Sivridis E; Georgoulias V; Harris AL; Gatter KC Oncol Res; 2000; 12(1):33-41. PubMed ID: 11061344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]